By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Oculus Innovative Sciences, Inc. 

1135 North McDowell Boulevard

Petaluma  California  94954  U.S.A.
Phone: 707-782-0792 Fax: 707-782-0705


SEARCH JOBS

Oculus Innovative Sciences is a biopharmaceutical company that develops, manufactures, and markets a family of Microcyn® Technology-based products intended to help prevent and treat infections in chronic and acute wounds. Oculus’ platform technology, called Microcyn, is a non-irritating proprietary oxychlorine formulation designed to treat a wide range of pathogens, including antibiotic-resistant strains of bacteria, viruses, fungi and spores.

Oculus’ principal operations are in Petaluma, California, and it conducts operations in Europe and Latin America through its wholly-owned subsidiaries, Oculus Innovative Sciences Netherlands B.V. and Oculus Technologies of Mexico, S.A. de C.V.

Last Updated: 05-23-2007

Key Statistics


Email: hr@oculusis.com
Ownership: Public

Web Site: Oculus Innovative Sciences, Inc.
Employees:
Symbol: OCLS
 









Company News
Oculus Innovative Sciences, Inc. (OCLS) Reports Financial Results For The First Quarter Of Fiscal Year 2016 7/31/2015 7:46:34 AM
Oculus Innovative Sciences, Inc. (OCLS) Announces Fiscal First Quarter 2016 Financial Results And Conference Call 7/16/2015 7:49:31 AM
Oculus Innovative Sciences, Inc. (OCLS) Receives New U.S. Patent For Microcyn Technology In Treatment Of Atopic Dermatitis 7/8/2015 7:19:37 AM
Oculus Innovative Sciences, Inc. (OCLS) Regains Compliance With Nasdaq Minimum Bid Price Rule 6/18/2015 7:47:31 AM
Oculus Innovative Sciences, Inc. (OCLS) Announces Sale Of 1.65 Million Shares Of Ruthigen Stock For $4.5 Million In Non-Dilutive Funding 6/16/2015 7:30:22 AM
Oculus Innovative Sciences, Inc. (OCLS) Reports Financial Results For The Fourth Quarter Of Fiscal Year 2015 6/12/2015 7:28:59 AM
Oculus Innovative Sciences, Inc. (OCLS) Receives FDA Clearance For Novel Atopic Dermatitis Dermatology Product 6/9/2015 8:07:29 AM
Oculus Innovative Sciences, Inc. (OCLS) Announces Fiscal Fourth Quarter 2015 Financial Results And Conference Call 5/28/2015 5:29:16 AM
Oculus Innovative Sciences, Inc. (OCLS) Announces Launch Of Microcynah Farm And Ranch Animal Healthcare Products 4/16/2015 7:57:51 AM
Oculus Innovative Sciences, Inc. (OCLS) Announces Sale Of 350,000 Shares Of Ruthigen Stock For $962,500 In Non-Dilutive Funding 3/16/2015 7:25:18 AM
12345678910...
//-->